Income Tax Expense

$869.30M

TTM · Period ending: Jun 30, 2026 · USD

VRTX Income Tax Expense

Latest reported$869.30Mperiod endingJun 30, 2026

VRTX TTM Income Tax ($0.00 → $869.30M)

TTM income tax expense

High-resolution chart · PNG

VRTX income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Income Tax Expense — Trailing twelve months (TTM) (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2026	869,300,000
Mar 31, 2026	827,400,000
Dec 31, 2025	690,000,000
Sep 30, 2025	773,600,000
Jun 30, 2025	736,400,000
Mar 31, 2025	688,700,000
Dec 31, 2024	784,100,000
Sep 30, 2024	739,400,000
Jun 30, 2024	704,600,000
Mar 31, 2024	748,000,000
Dec 31, 2023	760,200,000
Sep 30, 2023	839,300,000
Jun 30, 2023	941,300,000
Mar 31, 2023	909,400,000
Dec 31, 2022	910,400,000
Sep 30, 2022	753,300,000
Jun 30, 2022	738,213,000
Mar 31, 2022	413,134,000
Dec 31, 2021	388,256,000
Sep 30, 2021	571,889,000
Jun 30, 2021	419,513,000
Mar 31, 2021	518,192,000
Dec 31, 2020	405,151,000
Sep 30, 2020	214,434,000
Jun 30, 2020	149,145,000
Mar 31, 2020	221,356,000
Dec 31, 2019	218,109,000
Sep 30, 2019	-1,368,206,000
Jun 30, 2019	-1,373,299,000
Mar 31, 2019	-1,422,669,000
Dec 31, 2018	-1,486,862,000
Sep 30, 2018	15,994,000
Jun 30, 2018	-117,964,000
Mar 31, 2018	-123,968,000
Dec 31, 2017	-107,324,000
Sep 30, 2017	-125,034,000
Jun 30, 2017	1,372,000
Mar 31, 2017	15,165,000
Dec 31, 2016	16,665,000
Sep 30, 2016	22,739,000
Jun 30, 2016	23,566,000
Mar 31, 2016	35,567,000
Dec 31, 2015	30,381,000
Sep 30, 2015	33,803,000
Jun 30, 2015	35,892,000
Mar 31, 2015	6,454,000
Dec 31, 2014	6,958,000
Sep 30, 2014	-150,789,000
Jun 30, 2014	-154,959,000
Mar 31, 2014	-157,451,000
Dec 31, 2013	-288,567,000
Sep 30, 2013	-135,559,000
Jun 30, 2013	-113,453,000
Mar 31, 2013	-91,591,000
Dec 31, 2012	38,754,000
Sep 30, 2012	64,110,000
Jun 30, 2012	14,913,000
Mar 31, 2012	19,298,000
Dec 31, 2011	19,266,000
Sep 30, 2011	-32,668,000
Jun 30, 2011	-4,826,000
Mar 31, 2011	-29,274,000
Dec 31, 2010	-29,274,000
Sep 30, 2010	-483,534,000
Jun 30, 2010	-483,534,000
Mar 31, 2010	-483,534,000
Dec 31, 2009	-483,534,000
Sep 30, 2009	2,110,000
Jun 30, 2009	2,411,000
Mar 31, 2009	2,411,000
Dec 31, 2008	2,411,000
Sep 30, 2008	-5,420,000
Jun 30, 2008	-5,721,000
Mar 31, 2008	-5,721,000
Dec 31, 2007	-5,721,000
Sep 30, 2007	-179,547,000
Jun 30, 2007	-179,547,000
Mar 31, 2007	-179,547,000
Dec 31, 2006	-181,449,000
Sep 30, 2006	16,233,000
Jun 30, 2006	16,233,000
Mar 31, 2006	16,233,000
Dec 31, 2005	18,135,000
Sep 30, 2005	14,691,000
Jun 30, 2005	14,691,000
Mar 31, 2005	14,691,000
Dec 31, 2004	14,691,000
Sep 30, 2004	-67,046,000
Jun 30, 2004	-23,482,000
Mar 31, 2004	-67,613,000
Dec 31, 2003	-67,613,000
Sep 30, 2003	-43,653,000
Jun 30, 2003	-87,217,000
Mar 31, 2003	-46,093,000
Dec 31, 2002	-50,089,000
Sep 30, 2002	-16,906,000
Jun 30, 2002	9,670,000
Mar 31, 2002	12,677,000
Dec 31, 2001	10,148,000
Sep 30, 2001	16,904,000